Lipoarabinomannans: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy

Citation
J. Nigou et al., Lipoarabinomannans: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy, BIOCHEM J, 337, 1999, pp. 453-460
Citations number
42
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL JOURNAL
ISSN journal
02646021 → ACNP
Volume
337
Year of publication
1999
Part
3
Pages
453 - 460
Database
ISI
SICI code
0264-6021(19990201)337:<453:LCOTMF>2.0.ZU;2-L
Abstract
Lipoarabinomannans. which exhibit a large spectrum of immunological activit ies, emerge as the major antigens of mycobacterial envelopes. The lipoarabi nomannan structure is based on a phosphatidyl-myo-inositol anchor whose int egrity has been shown to be crucial for lipoarabinomannan biological activi ty and particularly for presentation to CD4/CD8 double-negative alpha beta T cells by CD1 molecules. In this report, an analytical approach was develo ped for high-resolution P-31-NMR analysis of native, i.e, multiacylated, li poarabinomannans. The one-dimensional P-31 spectrum of cellular lipoarabino mannans, from Mycobacterium bovis Bacillus Calmette-Guerin, exhibited four P-31 resonances typifying four types of lipoarabinomannans. Two-dimensional H-1-P-31 heteronuclear multiple-quantum-correlation/homonuclear Hartmann-H ahn analysis of the native molecules showed that these four types of lipoar abinomannan differed in the number and localization of fatty acids (from 1 to 4) esterifying the anchor. Besides the three acylation sites previously described, i.e. positions 1 and 2 of glycerol and 6 of the mannosyl unit li nked to the C-2 of myo-inositol, we demonstrate the existence of a fourth a cylation position at the C-3 of myo-inositol. We report here the first stru ctural study of native multiacylated lipoarabinomannans, establishing the s tructure of the intact phosphatidyl-myo-inositol anchor. Our findings would help gain more understanding of the molecular basis of lipoarabinomannan d iscrimination in the binding process to CD1 molecules.